Christian Thiede

Hematology — University Hospital Carl Gustav Carus, Germany

LeadR Profile

2 170 ScienceLeadR Reputation 2170
Network Map

Hematology

Subspecialties: Oncology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1997 - 2026

Source: PubMed

TU Dresden

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 631

Citations

Citations: 31 261 1st author: 29 Last author: 72 Unique author: 3


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
A platform of serially transplantable AML PDX models covering subgroups for which no cell lines exist.
cells, leukemia, cell line, research, therapeutics
Hemasphere20260
Intensive Chemotherapy and Tyrosine Kinase Inhibitor in Patients with De Novo BCR::ABL1+ Acute Myeloid Leukemia.
hematology, classification, leukemia, drug therapy, leukemia, myeloid, acute, leukemia, myeloid, protein-tyrosine kinases, tyrosine, chemotherapy
Blood20260
Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.
hematology, cytarabine, leukemia, leukemia, myeloid, acute, leukemia, myeloid, mitoxantrone, transplants, therapeutics
Haematologica20260
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.
cells, fms-like tyrosine kinase 3, microscopy, electron, scanning transmission, stem cells, maintenance, protein-tyrosine kinases, transplants, tyrosine, therapeutics, cell transplantation, stem cell transplantation, vascular endothelial growth factor receptor-1, mutation, transplantation
Br J Haematol20260
RNA Sequencing Indicates Distinct Platelet Transcriptomic Changes in Immune Thrombocytopenia.
up-regulation, genes, drug therapy, therapeutics, thrombosis, blood platelets, platelet activation, thrombocytopenia, purpura, thrombocytopenic, idiopathic, rna, chemotherapy
J Thromb Haemost20261

Clinical Studies 16

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 6
N/A 3
Phase 2 3
Phase 1/Phase 2 2
Phase 4 2

By status:

Completed 11
Recruiting 2
Unknown 2
Terminated 1

By type:

Interventional 13
Observational 3

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 2
multicentric5to9 2
multicentricup10 8

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map